Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

51.06
+0.77001.53%
Post-market: 50.94-0.1200-0.24%19:30 EDT
Volume:3.08M
Turnover:156.42M
Market Cap:103.28B
PE:16.33
High:51.08
Open:50.72
Low:50.62
Close:50.29
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.18
T/O Rate:0.16%
Dividend:1.82
Dividend Rate:3.56%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.38
PE(LYR):13.67

Loading ...

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

TIPRANKS
·
Jun 26

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

TIPRANKS
·
Jun 26

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
Jun 26

GSK to Deliver Earnings Growth over Next Decade

Dow Jones
·
Jun 25

Gsk's HIV Franchise Seems Underappreciated

Dow Jones
·
Jun 25

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 25

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

TIPRANKS
·
Jun 25

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live
·
Jun 25

GSK Discloses Executive Notional ADS Acquisition by U.S. President

TIPRANKS
·
Jun 24

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

TIPRANKS
·
Jun 24

GSK Climbs Tuesday, Outperforms Market

Dow Jones
·
Jun 24

GSK board members boost holdings with coordinated share purchases

TIPRANKS
·
Jun 23

GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk

Dow Jones
·
Jun 23

GSK Expands Treasury Stock Position with June Share Buybacks

TIPRANKS
·
Jun 22

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

TIPRANKS
·
Jun 19

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

TIPRANKS
·
Jun 19

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Jun 19

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GlobeNewswire
·
Jun 18

GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections

MT Newswires Live
·
Jun 18

GSK, Spero Therapeutics announce FDA approval of Utebzi

TIPRANKS
·
Jun 17